Skip to Content

Dantrolene Pregnancy and Breastfeeding Warnings

Dantrolene is also known as: Dantrium, Dantrium Intravenous, Revonto, Ryanodex

Dantrolene Pregnancy Warnings

Dantrolene has been assigned to pregnancy category C by the FDA. Studies in animals have revealed evidence of embryotoxicity. There are no controlled data in human pregnancy. Dantrolene should only be given during pregnancy when benefit outweighs risk.

Dantrolene has been used in one uncontrolled study prophylactically prior to and after delivery in obstetric patients who were at risk for malignant hyperthermia. Relatively low doses of 100 mg/day were used 5 days prior to and 3 days after delivery. Although dantrolene crossed the placenta, no untoward effects were noted in the fetuses or neonates.

See references

Dantrolene Breastfeeding Warnings

There are no data on the excretion of dantrolene into human milk. The manufacturer recommends that dantrolene not be used in nursing mothers.

See references

References for pregnancy information

  1. "Product Information. Dantrium (dantrolene)." Procter and Gamble Pharmaceutic, Cincinnati, OH.
  2. Pennati A, Sacchetti E, Calzeroni A "Dantrolene in lethal catatonia." Am J Psychiatry 148 (1991): 268

References for breastfeeding information

  1. "Product Information. Dantrium (dantrolene)." Procter and Gamble Pharmaceutic, Cincinnati, OH.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.